Drug Profile
PF 1163A
Alternative Names: (-)-PF1163ALatest Information Update: 04 Dec 2006
Price :
$50
*
At a glance
- Originator Meiji Seika Kaisha
- Class Macrocyclic compounds; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 13 Dec 2002 Preclinical trials in Mycoses in Japan (unspecified route)
- 25 May 2000 Preclinical development for Mycoses in Japan (Unknown route)